Oppenheimer Reiterates PDS Biotechnology (PDSB) at Outperform, "Broader Market Recovery Could be Particularly Supportive" for the Stock
Tweet Send to a Friend
Oppenheimer analyst Leland Gershell reiterated an Outperform rating and $25.00 price target on PDS Biotechnology Corp (NASDAQ: PDSB) after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
